13-Cis retinoic acid enhances in vivo B-lymphocyte differentiation in patients with common variable immunodeficiency
- 30 November 1991
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 88 (5) , 705-712
- https://doi.org/10.1016/0091-6749(91)90176-o
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Effects of 13-Cis Retinoic Acid Therapy on Human Antibody Responses to Defined Protein AntigensJournal of Investigative Dermatology, 1990
- Leu-8/TQ1 is the human equivalent of the Mel-14 lymph node homing receptorNature, 1989
- Failure of B cells in common variable immunodeficiency to transit from proliferation to differentiation is associated with altered B cell surface-molecule displayJournal of Allergy and Clinical Immunology, 1989
- Retinoic acid induces the differentiation of B cell hybridomas from patients with common variable immunodeficiency.The Journal of Experimental Medicine, 1988
- Designed transfer of specific immune responses with bone marrow transplantation.Journal of Clinical Investigation, 1986
- Immunological aspects of retinoids in humansCellular Immunology, 1984
- Identification of B-cell and T-helper-cell defects, and of suppressor cell hyperactivity, in humoral immunodeficiencyClinical Immunology and Immunopathology, 1984
- Inability of patients with common variable hypogammaglobulinemia to generate lymphoblastoid B cells following booster immunizationClinical Immunology and Immunopathology, 1980
- Prolonged Remissions of Cystic and Conglobate Acne with 13-cis-Retinoic AcidNew England Journal of Medicine, 1979
- Role of Helper, Suppressor and B-Cell Defects in the Pathogenesis of the HypogammaglobulinemiasNew England Journal of Medicine, 1978